X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (110) 110
humans (108) 108
index medicus (96) 96
male (65) 65
female (62) 62
adolescent (54) 54
adult (47) 47
hemophilia (46) 46
child (45) 45
peripheral vascular disease (45) 45
middle aged (37) 37
von willebrand disease (36) 36
children (32) 32
young adult (31) 31
child, preschool (30) 30
von willebrand factor (30) 30
surgery (28) 28
diagnosis (27) 27
risk factors (25) 25
risk (22) 22
sickle cell disease (22) 22
bleeding (21) 21
aged (20) 20
blood coagulation factor viii (20) 20
infant (20) 20
factor-viii (19) 19
hemophilia a (19) 19
netherlands (19) 19
pharmacokinetics (19) 19
analysis (18) 18
factor viii - immunology (18) 18
factor viii - therapeutic use (18) 18
hemophilia a - immunology (18) 18
management (17) 17
mortality (17) 17
phenotype (17) 17
sickle cell anemia (17) 17
hemophilia a - drug therapy (16) 16
pediatrics (16) 16
prophylaxis (16) 16
infant, newborn (15) 15
adult patients (14) 14
factor viii (14) 14
mutation (14) 14
retrospective studies (14) 14
severity of illness index (14) 14
anemia (13) 13
cross-sectional studies (13) 13
haemophilia (13) 13
recombinant factor-viii (13) 13
abridged index medicus (12) 12
age (12) 12
genotype (12) 12
hemophilia a - blood (12) 12
hemophilia a - genetics (12) 12
hemorrhage (12) 12
patient (12) 12
thrombosis (12) 12
treatment outcome (12) 12
age factors (11) 11
aged, 80 and over (11) 11
anemia, sickle cell - complications (11) 11
cohort studies (11) 11
disease (11) 11
previously untreated patients (11) 11
risk-factors (11) 11
surveys and questionnaires (11) 11
classification (10) 10
factor viii - genetics (10) 10
hemorrhage - etiology (10) 10
inhibitors (10) 10
medical research (10) 10
moderate (10) 10
patients (10) 10
population (10) 10
prevalence (10) 10
quality of life (10) 10
von willebrand factor - metabolism (10) 10
anemia, sickle cell - blood (9) 9
arthropathy (9) 9
coagulation factors (9) 9
factor viii - administration & dosage (9) 9
infants (9) 9
prospective studies (9) 9
quality-of-life (9) 9
blood (8) 8
care and treatment (8) 8
continuous-infusion (8) 8
europe (8) 8
hemophilia a - therapy (8) 8
human (8) 8
medicine, experimental (8) 8
mild (8) 8
therapy (8) 8
von-willebrand-factor (8) 8
activation (7) 7
adolescents (7) 7
australia (7) 7
factor-viii inhibitors (7) 7
haemophilia a (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of thrombosis and haemostasis, ISSN 1538-7933, 2015, Volume 13, Issue 6, pp. 956 - 966
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2014, Volume 12, Issue 7, pp. 1066 - 1075
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2015, Volume 13, Issue 7, pp. 1217 - 1225
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2013, Volume 11, Issue 5, pp. 845 - 854
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 122, Issue 11, pp. 1954 - 1962
Journal Article
Journal Article
Haemophilia, ISSN 1351-8216, 2015, Volume 21, Issue 3, pp. e185 - e192
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2012, Volume 108, Issue 4, pp. 683 - 692
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2018, Volume 16, Issue 12, pp. 2413 - 2424
Essentials It is unclear whether there are differences between von Willebrand factor (VWF) activity assays. We compared the four most used VWF activity assays... 
blood coagulation disorders | subtype classification | von Willebrand disease | clinical laboratory techniques | von Willebrand factor | PANEL | VWF | PERFORMANCE | CLASSIFICATION | DISEASE | PERIPHERAL VASCULAR DISEASE | RISTOCETIN COFACTOR | HEMATOLOGY | BINDING | PROPEPTIDE | Monoclonal antibodies | Von Willebrand factor | Platelets | Health risk assessment | Ristocetin | Classification
Journal Article
Blood, ISSN 0006-4971, 2014, Volume 124, Issue 15, pp. 2333 - 2336
The risk for inhibitor development in mild hemophilia A (factor VIII levels between 5 and 40 U/dL) is larger than previously anticipated, continues throughout... 
MODERATE HEMOPHILIA | RESPONSIVENESS | FACTOR-VIII INHIBITORS | MUTATION | DISEASE | DISORDERS | DESMOPRESSIN DDAVP | EXPERIENCE | MORTALITY-RATES | HEMATOLOGY | CHILDREN | Animals | Hemophilia A - immunology | Humans | Risk Factors | Antibodies - immunology | Hemophilia A - prevention & control | Hemophilia A - drug therapy | Spotlight | 100
Journal Article